Related Experiment Video
Updated: Apr 9, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
MicroRNA-137 Controls AMPA-Receptor-Mediated Transmission and mGluR-Dependent LTD
Nikkie F M Olde Loohuis1, Wei Ba2, Peter H Stoerchel3
1Department of Cognitive Neuroscience, Radboudumc, 6500 HB Nijmegen, the Netherlands; Donders Institute for Brain, Cognition, and Behaviour, Centre for Neuroscience, 6525 AJ Nijmegen, the Netherlands.
Abstract:
Mutations affecting the levels of microRNA miR-137 are associated with intellectual disability and schizophrenia. However, the pathophysiological role of miR-137 remains poorly understood. Here, we describe a highly conserved miR-137-binding site within the mRNA encoding the GluA1 subunit of AMPA-type glutamate receptors (AMPARs) and confirm that GluA1 is a direct target of miR-137. Postsynaptic downregulation of miR-137 at the CA3-CA1 hippocampal synapse selectively enhances AMPAR-mediated synaptic transmission and converts silent synapses to active synapses. Conversely, miR-137 overexpression selectively reduces AMPAR-mediated synaptic transmission and silences active synapses. In addition, we find that miR-137 is transiently upregulated in response to metabotropic glutamate receptor 5 (mGluR5), but not mGluR1 activation. Consequently, acute interference with miR-137 function impedes mGluR-LTD expression. Our findings suggest that miR-137 is a key factor in the control of synaptic efficacy and mGluR-dependent synaptic plasticity, supporting the notion that glutamatergic dysfunction contributes to the pathogenesis of miR-137-linked cognitive impairments.
Insights
MicroRNA miR-137 regulates synaptic transmission by targeting GluA1 AMPA receptors. Its downregulation enhances synaptic efficacy, while overexpression silences synapses, impacting cognitive functions.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Mutations in microRNA miR-137 are linked to cognitive disorders like intellectual disability and schizophrenia.
- The precise role of miR-137 in brain function and disease pathogenesis is not fully understood.
Purpose of the Study:
- To investigate the direct molecular targets and synaptic functions of microRNA miR-137.
- To elucidate the role of miR-137 in regulating synaptic plasticity and its connection to glutamatergic signaling.
Main Methods:
- Bioinformatic analysis to identify miR-137 binding sites on target mRNAs.
- Experimental validation of GluA1 as a direct miR-137 target.
- Electrophysiological recordings in hippocampal slices to assess synaptic transmission and plasticity.
- Manipulation of miR-137 levels in neurons.
Main Results:
- A conserved miR-137 binding site was identified in the mRNA of GluA1, a subunit of AMPA-type glutamate receptors (AMPARs), confirming GluA1 as a direct target.
- Downregulation of miR-137 at hippocampal synapses enhanced AMPAR-mediated transmission and activated silent synapses.
- Overexpression of miR-137 reduced AMPAR transmission and silenced active synapses.
- miR-137 was transiently upregulated by metabotropic glutamate receptor 5 (mGluR5) activation, and its inhibition impaired mGluR-dependent long-term depression (LTD).
Conclusions:
- MicroRNA miR-137 plays a critical role in controlling synaptic efficacy and regulating mGluR-dependent synaptic plasticity.
- Dysregulation of miR-137 and subsequent glutamatergic dysfunction may contribute to the cognitive impairments associated with miR-137-related disorders.
Related Concept Videos
MicroRNAs
MicroRNAs
GPCR Desensitization
Ligand-Gated Ion Channel Receptor: Gating Mechanism

